Pricing

Unleashing CDMO Growth through Effective Pricing

In the rapidly evolving industry of contract development and manufacturing organizations (CDMOs), a well-defined pricing strategy is essential to drive growth and profitability. To stay ahead and participate in the expansion of the market, CDMOs need to transition to a structured value-based pricing approach that considers customer value, complexity, and specific needs.

Deck of “Trump Cards” Collapses Pharma Deal

After a roller coaster ride entailing months of on again-off again negotiations with US president Donald Trump over drug prices, the country’s pharmaceutical industry is licking its wounds and gearing up for a fight.

Why CDMOs Should Consider Value-Based Pricing

Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.

Novartis to Close US Generics Unit, Keep Roche Stake

MEPs Take on EU Drug Pricing

On-demand Webinar: Best Practices to Improve Sales & Marketing Effectiveness in Chemicals

Pharma Shares Rise on Trump Victory

Leaving the Patent Cliff Behind

Substance-based Supply-Chain Planning under BEPS

European Price Wars Seen Shaping up Over Hepatitis C Drugs

Express Scripts to Reimburse AbbVie Hepatitis C Drug

China’s rising salaries improve Europe’s competitiveness

Sinopec to Cut Spending After Earnings Drop

Countering Commoditization

Drugmakers Face More Scrutiny of Discordant U.S. Prices

Platts Bans Vitol from Europe Naphtha "Window" Trade

Vitol's Dominance Grows in Cash European Oil Markets

China to Cut Prices of More than 400 Drugs from February

More Pressure to Justify Cost of Cancer Drugs Versus Benefits

Pricing Strategies

Pricing in the Chemical Sector

Novo Bets on High-Price Niche for Obesity Drug

GSK and J&J Lead Rivals in Drug Access for Poor

PGNiG Looks to Pass on Price Cut to Customers

India Revokes Roche Patent in New Blow for Big Pharma

Greece Fights Drug Shortages by Suspending Exports

Canada's Top Court Rules for Glaxo in Tax Case

Spain Coughs up Billions to Keep Regions in Medicine

Drugmakers Slam "Punitive" German Pricing Measures

Drugmakers Weigh Emergency Supply Plan for Greece

Air Products To Hike North American Prices & Service Charges

German 2011 Chemical Sector Growth Seen At 9%

Cutting Drug Prices Hampers New Development

Novo Nordisk Says Accepts New Greek Insulin Prices

Novo Pulls Drugs from Greece Over Price Cuts